Eris Lifesciences

BSE: 540596 | NSE: ERIS
Eris Lifesciences (CIN: L24232GJ2007PLC049867) operates in the Pharmaceuticals industry and has been listed in the stock market since 29th Jun 2017. It currents trades on NSE with symbol ERIS and on BSE with scrip code 540596.
The registered office of the company is 8th floor, Commerce House IV, Beside Shall Petrol Pump, 100 Feet Road, Prahladnagar,Ahmedabad,Gujarat,380015.

The management team of Eris Lifesciences is led by Mr. Amit Indubhushan Bakshi who is the Executive Director-Chairperson related to Promoter. Other members of the management team consist of Sachin Shah (Designation:Chief Financial Officer), Mr. Himanshu Jayantbhai Shah (Designation:Executive Director), Mr. Inderjeet Singh Negi (Designation:Executive Director), Mrs. Vijaya Sampath (Designation:Non-Executive - Independent Director), Mr. Kirit Nanubhai Shelat (Designation:Non-Executive - Independent Director), Mr. Prashant Gupta (Designation:Non-Executive - Independent Director), Milind Talegaonkar (Designation:Company Secretary & Compliance Officer), .

The price and other financial information of Eris Lifesciences is as below -

BSE 442.4 -2.85 (-0.64%)

BSE

442.4 -2.85 (-0.64%)
Volume: 5,047.00
M. Cap: 6,168.00
P/E: 20.24
Prev. Close: 445.25
Day
52 Wk

NSE

447.95 3.45 (0.78%)
Volume: 44,017.00
M. Cap: 6,168.00
P/E: 20.24
Prev. Close: 444.50
Day
52 Wk

Stock Price Chart

Shareholding Pattern

Category No. of shares Percent(%)
Promoters 7,73,31,807 56.23
General Public 3,29,34,076 23.95
NBFC and Mutual Funds 1,76,62,093 12.84
Foreign Institutions 83,32,571 6.06
Financial Institutions 8,18,328 0.60
Others 4,40,908 0.32
Total 13,75,19,783 100

NSE Trade Data

Trade Snapshot
VWAP 441.69
Face Value 1.00
Traded Volume (shares) 44,018.00
Traded Value (lacs) 194.42
Free Float Market Cap (Crs) 1,283.68
52 week high 746.00
52 week low 358.10
Lower Price Band 355.60
Upper Price Band 533.40
Security-wise Delivery Position
Quantity Traded 36,313.00
Deliverable Quantity (gross across client level) 17,213.00
% of Deliverable Quantity to Traded Quantity 47.40 %
Value at Risk (VaR in %)
Security VaR 8.77
Index VaR -
VAR Margin 8.77
Extreme Loss Rate 5.00
Adhoc Margin -
Applicable Margin Rate 13.77

Financial Data

Consolidated
Figures in crore 2019 2018 2017
Net Sales 982.16 855.60 749.50
Operating Profit 376.77 348.52 294.25
Other Income 31.69 26.41 25.11
Interest 23.06 10.65 1.10
Depreciation 36.35 25.64 22.76
Profit Before Tax 317.36 312.23 270.39
Tax 26.21 17.25 23.78
Profit After Tax 291.15 294.98 246.61
Share Capital 13.75 13.75 13.75
Reserves 1,136.77 847.56 553.39
Net Worth 1,150.52 861.31 567.14
Loans 176.42 376.80 0.65
Gross Block 838.26 819.52 254.43
Investments 355.85 365.37 303.23
Cash 7.51 10.64 2.42
Debtors 83.98 66.64 48.86
Net Working Capital 230.54 130.39 65.44
Operating Profit Margin (%) 38.36 40.73 39.26
Net Profit Margin (%) 29.64 34.48 32.90
Earning Per Share (Rs) 21.15 21.39 17.95
Dividend (%) 0.00 0.00 0.00
Dividend Payout 0.00 0.00 0.00
Standalone
Figures in crore 2019 2018 2017
Net Sales 896.54 760.60 712.90
Operating Profit 366.27 344.16 296.27
Other Income 32.50 28.22 25.08
Interest 22.90 10.48 0.85
Depreciation 31.59 21.79 21.44
Profit Before Tax 311.78 311.89 273.98
Tax 26.40 18.23 25.84
Profit After Tax 285.38 293.66 248.14
Share Capital 13.75 13.75 13.75
Reserves 1,142.26 854.43 560.85
Net Worth 1,156.01 868.18 574.60
Loans 199.65 393.98 21.28
Gross Block 551.81 532.93 113.20
Investments 580.47 545.60 380.61
Cash 6.47 8.81 2.06
Debtors 75.90 60.50 41.30
Net Working Capital 288.59 226.81 123.50
Operating Profit Margin (%) 40.85 45.25 41.56
Net Profit Margin (%) 31.83 38.61 34.81
Earning Per Share (Rs) 20.75 21.36 18.05
Dividend (%) 0.00 0.00 0.00
Dividend Payout 0.00 0.00 0.00

Financial Data Graph

The peers of Eris Lifesciences are DRREDDY, SUVEN and SHILPAMED. You can get more detailed information on those company by clicking on the respective names.

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*

Popular Comments

No comment posted for this article.